BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Sus Clinicals - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Sus Clinicals
X-ORIGINAL-URL:https://susclinicals.com
X-WR-CALDESC:Events for Sus Clinicals
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250425
DTEND;VALUE=DATE:20250501
DTSTAMP:20260410T165637
CREATED:20250422T151238Z
LAST-MODIFIED:20260204T175526Z
UID:27489-1745539200-1746057599@susclinicals.com
SUMMARY:AACR Annual Meeting 2025
DESCRIPTION:Sus Clinicals\, Inc. is delighted to participate in this year’s American Association of Cancer Research Annual Meeting in Chicago\, beginning on Friday\, April 25. \nSus Clinicals’ Principal R&D Scientist Dr. Mahmoud Khalafalla will be presenting some of our latest research on April 29 at 2pm. \nHis presentation will cover “Validation of genetically defined Oncopig® hepatocellular carcinoma (HCC) cell lines for in vitro evaluation of targeted therapeutic efficacy.” \nBuilding on our success developing histology-specific tumor induction models (such as HCC)\, recent work demonstrates our ability to develop Oncopig HCC cell lines with differential therapeutic susceptibilities through introduction of specific\, clinically relevant HCC driver mutations (PTEN\, etc.) via CRISPR-Cas9 gene editing. \nThis is particularly useful for researchers developing targeted therapeutics against specific driver mutations. \nIf you will be attending AACR and would like to speak with one of our team members to learn about how the Oncopig platform could accelerate your cancer research\, please contact us at info@susclinicals.com to schedule a meeting.
URL:https://susclinicals.com/event/aacr-2025/
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://susclinicals.com/wp-content/uploads/2025/04/austin-neill-H6k-1Fk3SOY-unsplash-scaled.jpg
END:VEVENT
END:VCALENDAR